Abstract

In the present study, murine RAW 264.7 macrophages were incubated with poly-L-lysine-derived advanced glycosylation end products (PLL-AGEs) to examine cyclooxygenase-2 protein expression. Treatment of RAW 264.7 cells with PLL-AGEs caused the dose-dependent expression of cylooxygenase-2 but not cylooxygenase-1 and an increase in cylooxygenase activity. Increased cylooxygenase-2 expression was seen at 6 h and reached a maximum at 24 h. The tyrosine kinase inhibitor, genistein, and the p38 mitogen-activated protein kinase (MAPK) inhibitor, [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] (SB 203580), inhibited PLL-AGE-induced cylooxygenase-2 expression, while the Ras inhibitor, FPT inhibitor II, and the MAP kinase kinase inhibitor, (2′-amino-3′-methoxyflavone) (PD 98059), had no effect on PLL-AGE-induced cylooxygenase-2 expression. Incubation of RAW 264.7 cells with PLL-AGEs resulted in activation of p38 MAPK, and this activation was suppressed by genistein and SB 203580. Taken together, our results suggest that activation of protein tyrosine kinase and p38 MAPK is involved in AGE-induced cyclooxygenase-2 expression in RAW 264.7 macrophages.

Original languageEnglish
Pages (from-to)143-152
Number of pages10
JournalEuropean Journal of Pharmacology
Volume438
Issue number3
DOIs
Publication statusPublished - Mar 8 2002

Fingerprint

Advanced Glycosylation End Products
p38 Mitogen-Activated Protein Kinases
Lysine
Genistein
Cyclooxygenase 2
Protein-Tyrosine Kinases
MAP Kinase Kinase 2
Macrophages
Protein Kinase Inhibitors
Proteins

Keywords

  • Advanced
  • Cyclooxygenase-2
  • Glycosylation end product
  • p38 MAP (mitogen activated protein) kinase
  • RAW 264.7 cell

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Involvement of p38 mitogen-activated protein kinase in PLL-AGE-induced cyclooxgenase-2 expression. / Lin, Chien-Huang; Wu, Chih Hsiung; Thum, Wai Yee; Ho, Yuan Sun; Lee, Horng Mo.

In: European Journal of Pharmacology, Vol. 438, No. 3, 08.03.2002, p. 143-152.

Research output: Contribution to journalArticle

@article{b35b971cde114ef8b610e39f2541dda6,
title = "Involvement of p38 mitogen-activated protein kinase in PLL-AGE-induced cyclooxgenase-2 expression",
abstract = "In the present study, murine RAW 264.7 macrophages were incubated with poly-L-lysine-derived advanced glycosylation end products (PLL-AGEs) to examine cyclooxygenase-2 protein expression. Treatment of RAW 264.7 cells with PLL-AGEs caused the dose-dependent expression of cylooxygenase-2 but not cylooxygenase-1 and an increase in cylooxygenase activity. Increased cylooxygenase-2 expression was seen at 6 h and reached a maximum at 24 h. The tyrosine kinase inhibitor, genistein, and the p38 mitogen-activated protein kinase (MAPK) inhibitor, [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] (SB 203580), inhibited PLL-AGE-induced cylooxygenase-2 expression, while the Ras inhibitor, FPT inhibitor II, and the MAP kinase kinase inhibitor, (2′-amino-3′-methoxyflavone) (PD 98059), had no effect on PLL-AGE-induced cylooxygenase-2 expression. Incubation of RAW 264.7 cells with PLL-AGEs resulted in activation of p38 MAPK, and this activation was suppressed by genistein and SB 203580. Taken together, our results suggest that activation of protein tyrosine kinase and p38 MAPK is involved in AGE-induced cyclooxygenase-2 expression in RAW 264.7 macrophages.",
keywords = "Advanced, Cyclooxygenase-2, Glycosylation end product, p38 MAP (mitogen activated protein) kinase, RAW 264.7 cell",
author = "Chien-Huang Lin and Wu, {Chih Hsiung} and Thum, {Wai Yee} and Ho, {Yuan Sun} and Lee, {Horng Mo}",
year = "2002",
month = "3",
day = "8",
doi = "10.1016/S0014-2999(02)01285-2",
language = "English",
volume = "438",
pages = "143--152",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Involvement of p38 mitogen-activated protein kinase in PLL-AGE-induced cyclooxgenase-2 expression

AU - Lin, Chien-Huang

AU - Wu, Chih Hsiung

AU - Thum, Wai Yee

AU - Ho, Yuan Sun

AU - Lee, Horng Mo

PY - 2002/3/8

Y1 - 2002/3/8

N2 - In the present study, murine RAW 264.7 macrophages were incubated with poly-L-lysine-derived advanced glycosylation end products (PLL-AGEs) to examine cyclooxygenase-2 protein expression. Treatment of RAW 264.7 cells with PLL-AGEs caused the dose-dependent expression of cylooxygenase-2 but not cylooxygenase-1 and an increase in cylooxygenase activity. Increased cylooxygenase-2 expression was seen at 6 h and reached a maximum at 24 h. The tyrosine kinase inhibitor, genistein, and the p38 mitogen-activated protein kinase (MAPK) inhibitor, [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] (SB 203580), inhibited PLL-AGE-induced cylooxygenase-2 expression, while the Ras inhibitor, FPT inhibitor II, and the MAP kinase kinase inhibitor, (2′-amino-3′-methoxyflavone) (PD 98059), had no effect on PLL-AGE-induced cylooxygenase-2 expression. Incubation of RAW 264.7 cells with PLL-AGEs resulted in activation of p38 MAPK, and this activation was suppressed by genistein and SB 203580. Taken together, our results suggest that activation of protein tyrosine kinase and p38 MAPK is involved in AGE-induced cyclooxygenase-2 expression in RAW 264.7 macrophages.

AB - In the present study, murine RAW 264.7 macrophages were incubated with poly-L-lysine-derived advanced glycosylation end products (PLL-AGEs) to examine cyclooxygenase-2 protein expression. Treatment of RAW 264.7 cells with PLL-AGEs caused the dose-dependent expression of cylooxygenase-2 but not cylooxygenase-1 and an increase in cylooxygenase activity. Increased cylooxygenase-2 expression was seen at 6 h and reached a maximum at 24 h. The tyrosine kinase inhibitor, genistein, and the p38 mitogen-activated protein kinase (MAPK) inhibitor, [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] (SB 203580), inhibited PLL-AGE-induced cylooxygenase-2 expression, while the Ras inhibitor, FPT inhibitor II, and the MAP kinase kinase inhibitor, (2′-amino-3′-methoxyflavone) (PD 98059), had no effect on PLL-AGE-induced cylooxygenase-2 expression. Incubation of RAW 264.7 cells with PLL-AGEs resulted in activation of p38 MAPK, and this activation was suppressed by genistein and SB 203580. Taken together, our results suggest that activation of protein tyrosine kinase and p38 MAPK is involved in AGE-induced cyclooxygenase-2 expression in RAW 264.7 macrophages.

KW - Advanced

KW - Cyclooxygenase-2

KW - Glycosylation end product

KW - p38 MAP (mitogen activated protein) kinase

KW - RAW 264.7 cell

UR - http://www.scopus.com/inward/record.url?scp=0037040405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037040405&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(02)01285-2

DO - 10.1016/S0014-2999(02)01285-2

M3 - Article

C2 - 11909605

AN - SCOPUS:0037040405

VL - 438

SP - 143

EP - 152

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -